IL7 and COVID-19: Additional mechanisms whereby IL-7 may act to decrease secondary nosocomial infections in patients with COVID-19 is its effect to reverse T cell exhaustion, which commonly occurs in patients with persistent viral infections including COVID-19 (51, 53).